FDA Inspection 1210240 — Loyola University Chicago Health Sciences Campus IRB

Loyola University Chicago Health Sciences Campus IRB — FEI 1470176

The FDA completed an inspection of Loyola University Chicago Health Sciences Campus IRB on June 23, 2023 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 23, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Maywood, IL (United States)

Additional Details

IRB